Gene therapy for murine mucopolysaccharidosis type VII
Open Access
- 31 July 1997
- journal article
- review article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 7 (5) , 352-360
- https://doi.org/10.1016/s0960-8966(97)00061-8
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Correction of the Growth Defect in Dwarf Mice with Nonautologous Microencapsulated Myoblasts—An Alternate Approach to Somatic Gene TherapyHuman Gene Therapy, 1995
- Adeno-associated virus (AAV) vectors: will they work?Journal of Clinical Investigation, 1994
- Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brainNature Genetics, 1994
- Enzyme replacement therapy for murine mucopolysaccharidosis type VII.Journal of Clinical Investigation, 1994
- CONTINUOUS SYSTEMIC SECRETION OF A LYSOSOMAL ENZYME BY GENETICALLY MODIFIED MOUSE SKIN FIBROBLASTSTransplantation, 1993
- Long‐term outcome of Hurler syndrome following bone marrow transplantationAmerican Journal of Medical Genetics, 1993
- Concepts and strategies for human gene therapyEuropean Journal of Biochemistry, 1992
- Gene Transfer in Human Lymphocytes Using a Vector Based on Adeno-Associated VirusJournal of Immunotherapy, 1992
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- Beta glucuronidase deficiency: Report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosisThe Journal of Pediatrics, 1973